Loading
ZA
Zelluna ASA Stock: price and insider trades · Norway
No insider purchase over the last 90 days. The latest was filed 04 Jan 2024.
Zelluna ASA: what insiders have been doing
This page follows insider dealings at Zelluna ASA as filed with Oslo Børs, a company from the Health Care sector. Over the twelve months to 18 October 2026, the company's managers filed 4 filings, from 3 insiders.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
There has been no open-market purchase by an insider of Zelluna ASA for at least a year.
Compared with its exchange (258 companies, median 4 filings), a count of 4 filings is typical. Our records for Zelluna ASA go back to 2021, with 20 purchases and 3 sales on the open market in total.
For comparison within the same sector, see the insider buying recorded at Cooper Companies, Inc. and Anixa Biosciences Inc. Source: insider filings from Oslo Børs. Past trades are no guide to future returns.
Insider Decl.
30
Thresholds
n/a
Buy Volume
€591,870
20 ops. · all time
Sell Volume
€1B
3 ops. · all time
Financial data
· cache
NOK 19.20
Last declaration on 2 July 2026
Declarations30 total
@ €1.6684OptionXOSLOSLO:677565
@ €1.6315ShareXOSLOSLO:677249
ShareXOSLOSLO:676434
@ €1.6528OptionXOSLOSLO:669613
@ €0.0876ShareXOSLOSLO:643069
ShareXOSLOSLO:642269
2,024,400,000 shares@ NOK 7.898499.9% of flowShareXOSLOSLO:613038
140,000 shares@ NOK 7.25070.0% of flowShareXOSLOSLO:613037
596,006 shares@ NOK 9.52450.0% of flowShareXOSLOSLO:612956
500 shares@ NOK 130.004.8% of flowOptionXOSLOSLO:608023
Canonical exit: 3 Apr 2024 (T+90)
1,500 shares@ NOK 119.7513.2% of flowOptionXOSLOSLO:607867
Canonical exit: 1 Apr 2024 (T+90)
500 shares@ NOK 114.004.0% of flowOptionXOSLOSLO:604609
Canonical exit: 19 Feb 2024 (T+90)
5,300 shares@ NOK 93.950.0% of flowShareXOSLOSLO:603354
Canonical exit: 6 Feb 2024 (T+90)
7,000 shares@ NOK 79.51590.0% of flowShareXOSLOSLO:592830
Canonical exit: 6 Sept 2023 (T+90)
7,100 shares@ NOK 70.000.0% of flowShareXOSLOSLO:592748
Canonical exit: 6 Sept 2023 (T+90)
1,500 shares@ NOK 96.705811.6% of flowOptionXOSLOSLO:576959
Canonical exit: 27 Feb 2023 (T+90)
5,250 shares@ NOK 94.5580.0% of flowShareXOSLOSLO:575427
Canonical exit: 8 Feb 2023 (T+90)
2,000 shares@ NOK 67.1011.2% of flowOptionXOSLOSLO:570550
Canonical exit: 4 Dec 2022 (T+90)
2,000 shares@ NOK 69.5011.1% of flowOptionXOSLOSLO:566134
Canonical exit: 28 Sept 2022 (T+90)
1,000 shares@ NOK 93.667.6% of flowOptionXOSLOSLO:554112
Canonical exit: 18 May 2022 (T+90)
1,000 shares@ NOK 107.608.6% of flowOptionXOSLOSLO:548429
Canonical exit: 2 Mar 2022 (T+90)
1,000 shares@ NOK 114.009.2% of flowOptionXOSLOSLO:548142
Canonical exit: 27 Feb 2022 (T+90)
5,000 shares@ NOK 77.68080.0% of flowShareXOSLOSLO:534618
Canonical exit: 26 Aug 2021 (T+90)
500 shares@ NOK 79.003.2% of flowOptionXOSLOSLO:534102
Canonical exit: 23 Aug 2021 (T+90)
25 of 30 declarations
About Zelluna ASA
Zelluna ASA is a company focused on the health and pharmaceutical sector, specializing in the development of immunological therapies. It is listed on the XOSL market.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
